Clinical Trial Update: Long-term Study of Romiplostim in Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP) [Phase 3]

View source ↗

Summary

Long-term phase 3 trial in pediatric patients with immune thrombocytopenia assessing romiplostim safety and efficacy; study completed with results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Romiplostim (romiplostim)

Snippet

Sponsor: Amgen | Conditions: Immune Thrombocytopenia | Phase 3 | Status: COMPLETED | Results posted: 2019-08-28